Vazquez Christopher's Insider Trades & SAST Disclosures
Vazquez Christopher's most recent trade in Biodesix Inc was a trade of 90,100 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Vazquez Christopher.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 90,100 | 90,100 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Vazquez Christopher | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 45,050 | 45,050 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 39,664 | 39,664 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 9,666 | 21,253 | - | - | Common Stock | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 4,694 | 9,388 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 4,371 | 13,112 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 10 Feb 2025 | 3,630 | 17,623 | - | 0.9 | 3,355 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 601 | 2,407 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 602 | 3,008 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 602 | 11,790 | - | - | Common Stock | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 08 Nov 2024 | 105 | 11,685 | - | 1.4 | 146 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.40 per share. | 08 Nov 2024 | 98 | 11,587 | - | 1.4 | 137 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 602 | 3,610 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 602 | 11,397 | - | - | Common Stock | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.60 per share. | 08 Aug 2024 | 155 | 11,242 | - | 1.6 | 248 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 08 Aug 2024 | 54 | 11,188 | - | 1.6 | 85 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 880 | 10,795 | - | - | Common Stock | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 22 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 601 | 10,159 | - | - | Common Stock | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 601 | 4,212 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.48 per share. | 08 May 2024 | 244 | 9,915 | - | 1.5 | 361 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 22 | 22 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Biodesix Inc | Vazquez Christopher | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 14,280 | 14,280 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 34,966 | 34,966 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 17,483 | 17,483 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,296 | 11,547 | - | - | Common Stock | |
| Biodesix Inc | Vazquez Christopher | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 4,694 | 14,082 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 08 Feb 2024 | 1,077 | 10,470 | - | 1.9 | 2,064 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 08 Feb 2024 | 922 | 9,548 | - | 1.7 | 1,535 | Common Stock |
| Biodesix Inc | Vazquez Christopher | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 602 | 4,813 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 1,417 | 6,424 | - | - | Common Stock | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 814 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 603 | 6,016 | - | - | Restricted Stock Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 08 Aug 2023 | 280 | 6,144 | - | 1.4 | 389 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 08 Aug 2023 | 279 | 5,865 | - | 1.3 | 353 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 03 Aug 2023 | 617 | 5,007 | - | 1.6 | 1,000 | Common Stock |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 16,000 | 0 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 3,266 | 3,266 | - | - | Stock Options (Right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges